Global Metagenomics Market Size to Exceed USD 6.21 Billion by 2033: Market Insight Report

RELEASE DATE: Apr 2025 Author: Spherical Insights
The Global Metagenomics Market Size Expected to Grow from USD 1.92 Billion in 2023 to USD 6.21 Billion by 2033, at a CAGR of 12.46 % during the forecast period 2023-2033.

Table of Contents

Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis


Related Topics

Zero-Waste Shampoo Market Size Propionaldehyde Market Size Golf Gloves Market Size Silver Tourism Market Size

Global Metagenomics Market Size to Exceed USD 6.21 Billion by 2033

According to a research report published by Spherical Insights & Consulting, the Global Metagenomics Market Size Expected to Grow from USD 1.92 Billion in 2023 to USD 6.21 Billion by 2033, at a CAGR of 12.46 % during the forecast period 2023-2033.  

 

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Metagenomics Market Size, Share, and COVID-19 Impact Analysis, By Technology (Shotgun Sequencing and Whole Genome Sequencing), By Product (Kits & Reagents and Sequencing & Data Analytics Services), By Workflow (Sequencing and Data Analysis), By Application (Environmental and Clinical Diagnostics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

 

The global metagenomics market is defined as the industry that develops, applies, and commercializes technologies and tools to analyze the genetic material (DNA/RNA) present in environmental samples, including soil, water, air, and human microbiomes, without culturing organisms in a laboratory. Continuous technological advancements, particularly in sequencing technologies with the advent of next-generation sequencing (NGS), which has been made more efficient, accurate, and cost-effective are one of the major drivers. Explorations into human, animal, and environmental microbiomes have created an increased demand for metagenomic research in understanding microbial communities' influence on health, immunity, and disease prevention. Another driving force in the growth of this market is environmental and industrial applications such as biodiversity monitoring, soil health assessment, and detection of pathogens. Additionally, personalized medicine and precision healthcare where metagenomics is applied in diagnostics and treatment through the analysis of the human microbiome expand the market significantly. Additionally, the environmental and agricultural sectors provide great opportunities. Metagenomics of microbial communities in soil, water, and plants can improve agriculture by enhancing soil health, and biodiversity, and aiding in pest management. One of the major challenges remains the high cost of sequencing technologies and the related infrastructure, limiting access to metagenomic tools, especially to smaller research institutions and developing regions. Even with falling prices, the cost of high-throughput sequencing platforms, reagents, and data storage remains a barrier to widespread adoption.

 

The shotgun sequencing segment accounted for the largest revenue share of the global metagenomics market over the forecast period.

On the basis of technology, the global metagenomics market is segmented into shotgun sequencing and whole genome sequencing. Among these, the shotgun sequencing segment accounted for the largest revenue share of the global metagenomics market over the forecast period. The segment growth can be attributed deo to the shotgun sequencing involves randomly breaking up DNA into small fragments and then sequencing these fragments in parallel. This method is very effective in analyzing complex microbial communities since it does not depend on prior knowledge of the organisms being studied. Shotgun sequencing offers a holistic view of the whole microbial genome and can identify and characterize a large number of microorganisms within a sample, including those that are difficult to culture or unknown.

 

The kits & reagents segment accounted for the largest revenue share of the global metagenomics market over the forecast period.

On the basis of product, the global metagenomics market is segmented into kits & reagents and sequencing & data analytics services. Among these, the kits & reagents segment accounted for the largest revenue share of global metagenomics market over the forecast period. The segment growth is driven because kits & reagents are vital for the successful execution of metagenomic studies since they are employed in sample collection, DNA/RNA extraction, amplification, and sequencing. These products contain a wide range of consumables such as DNA extraction kits, PCR reagents, sequencing reagents, and library preparation kits, which form the basis for the proper handling of biological samples.

 

The sequencing segment dominated the market with a revenue share of the global metagenomics market over the forecast period.

On the basis of application, the global metagenomics market is segmented into sequencing and data analysis. Among these, the sequencing segment dominated the market with a revenue share of the global metagenomics market over the forecast period. The segment growth is driven due to the sequencing offers the ability to identify the organisms present in a sample, including those that cannot be cultured in a laboratory setting, and provides insights into the genetic diversity, functional potential, and interactions within microbial ecosystems.

 

The clinical diagnostics segment is expected to grow at a significant CAGR during the forecast period.

On the basis of application, the global metagenomics market is segmented into environmental and clinical diagnostics. Among these, the clinical diagnostics segment is expected to grow at a significant CAGR during the forecast period. The clinical diagnostics segment is witnessing tremendous traction with the increasing awareness of the human microbiome in health and disease. Metagenomics in clinical diagnostics helps identify pathogens, microorganisms, and putative biomarkers for a vast array of diseases, including infections, cancer, autoimmune disorders, and gastrointestinal diseases.

 

North America is projected to hold the largest share of the global metagenomics market over the forecast period.

North America is projected to hold the largest share of the global metagenomics market over the forecast period. Advanced healthcare systems, cutting-edge research institutions, and strong funding for biotechnology and genomics are present in the region, which helps accelerate the rapid adoption and innovation of metagenomics. The United States and Canada have world-leading universities, research centers, and private companies at the forefront of microbiome and metagenomics research, which accelerates the development and application of sequencing technologies. Another factor driving growth in the market is the growing focus on personalized medicine in North America, where research on the microbiome plays an important role in tailoring treatments to individual patients.

 

Europe region is expected to grow at the fastest CAGR during the forecast period. Many factors contribute to the rapid growth of the biotechnology market, among them emphasis on research and innovation, increased investment by the government and private sectors in biotechnology, and increased adoption of metagenomics in both clinical and environmental settings. Many of the leading research institutes, universities, and companies focused on biotechnology are located within Europe, particularly the UK, Germany, France, and Switzerland, thereby leading the way in developing new metagenomic technologies.

 

Competitive Analysis

Major vendors in the global metagenomics market are Bio-Rad Laboratories, Inc, Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega Corporation, QIAGEN, Takara Bio, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche Ltd., and Others.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

        

Recent Development

  • In January 2023, QIAGEN announced closing the acquisition of Verogen, using GS technology for forensic and human identification to advance the future of Human Identification (HID) and forensics.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global metagenomics market based on the below-mentioned segments: 

 

Global Metagenomics Market, By Technology

  • Shotgun Sequencing
  • Whole Genome Sequencing

 

Global Metagenomics Market, By Product

  • Kits & Reagents
  • Sequencing & Data Analytics Services

 

Global Metagenomics Market, By Workflow

  • Sequencing
  • Data Analysis

 

Global Metagenomics Market, By Application

  • Environmental
  • Clinical Diagnostics

 

Global Metagenomics Market, Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Recent Insights


Your personal details are safe with us, Privacy Policy.

Thank You!

We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.

+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com

We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies